1. ALoun, A., Abu-Zeid, E.E.D. & Garzali, I.U. (2023) Does mtori base immunosuppression offer survival advantage after liver transplantation for hepatocellular carcinoma? Systematic review and meta-analysis of randomized controlled trials. Hepatol. Forum, 4, 82-88.
2. Aggarwal, S., Vadada, D. & Sharma, V. (2012) A rare complication in an adult patient after Kasai portoenterostomy for biliary atresia. Arab J. Gastroenterol., 13, 148-149.
3. Arai, Y., Kubota, M., Kobayashi, T., Ohyama, T. & Yokota, N. (2016) A case of synchronous combined cancer with intrahepatic cholangiocarcinoma and hepatocellular carcinoma 39 years after operation for biliary atresia. J. Jpn. Soc. Pediatr. Surg., 52, 1303-1308.
4. Azuhata, T., Koshinaga, T., Tanaka, M., Ikeda, T., Hagiwara, N., Takekawa, M., Nonaka, S., Fukazawa, M., Sugitani, M. & Nemoto, N. (2003) Hepatocellular carcinoma complicating biliary atresia caused by HCV infection: a case report. J. Jpn. Soc. Pediatr. Surg., 39, 765-770.
5. Brierley, J.D., Gospodarowicz,M.K. & Wittekind, C. (2017) TNM Classification ofMalignant Tumors, 8th ed., John Wiley-Blackwell, Hoboken, NJ, USA.